Insufficient scRNA-seq data for expression of CCN4 at single-cell level.
Insufficient scRNA-seq data for expression of CCN4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 95% | 1177.57 | 548 / 578 | 91% | 16.01 | 1046 / 1155 |
ovary | 95% | 852.08 | 171 / 180 | 72% | 8.74 | 308 / 430 |
uterus | 99% | 1399.68 | 169 / 170 | 64% | 11.86 | 296 / 459 |
kidney | 100% | 1241.07 | 89 / 89 | 62% | 7.49 | 560 / 901 |
intestine | 82% | 393.42 | 789 / 966 | 74% | 9.33 | 388 / 527 |
adrenal gland | 100% | 1388.75 | 258 / 258 | 45% | 4.00 | 103 / 230 |
bladder | 71% | 290.14 | 15 / 21 | 67% | 11.63 | 336 / 504 |
esophagus | 67% | 628.21 | 972 / 1445 | 70% | 10.20 | 128 / 183 |
breast | 37% | 92.39 | 169 / 459 | 94% | 24.25 | 1052 / 1118 |
prostate | 99% | 490.66 | 243 / 245 | 30% | 1.49 | 149 / 502 |
skin | 69% | 1889.37 | 1249 / 1809 | 58% | 5.81 | 276 / 472 |
stomach | 43% | 347.58 | 155 / 359 | 82% | 10.19 | 234 / 286 |
pancreas | 14% | 50.36 | 47 / 328 | 89% | 26.49 | 158 / 178 |
blood vessel | 99% | 871.13 | 1320 / 1335 | 0% | 0 | 0 / 0 |
spleen | 93% | 308.07 | 225 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 21.99 | 34 / 45 |
thymus | 51% | 138.37 | 330 / 653 | 18% | 1.57 | 109 / 605 |
heart | 63% | 246.06 | 540 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 5.46 | 18 / 29 |
adipose | 61% | 328.20 | 736 / 1204 | 0% | 0 | 0 / 0 |
liver | 35% | 126.68 | 78 / 226 | 18% | 1.74 | 74 / 406 |
brain | 1% | 1.30 | 22 / 2642 | 29% | 6.26 | 204 / 705 |
eye | 0% | 0 | 0 / 0 | 6% | 0.26 | 5 / 80 |
muscle | 2% | 4.72 | 20 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.28 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0007165 | Biological process | signal transduction |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0007155 | Biological process | cell adhesion |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_0007267 | Biological process | cell-cell signaling |
GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0060348 | Biological process | bone development |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0042593 | Biological process | glucose homeostasis |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0005615 | Cellular component | extracellular space |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0008201 | Molecular function | heparin binding |
GO_0005178 | Molecular function | integrin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CCN4 |
Protein name | CCN family member 4 (WNT1-inducible-signaling pathway protein 1) (WISP-1) (Wnt-1-induced secreted protein) Cellular communication network factor 4 |
Synonyms | WISP1 |
Description | FUNCTION: Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell survival. Attenuates p53-mediated apoptosis in response to DNA damage through activation of AKT kinase. Up-regulates the anti-apoptotic Bcl-X(L) protein. Adheres to skin and melanoma fibroblasts. In vitro binding to skin fibroblasts occurs through the proteoglycans, decorin and biglycan. . |
Accessions | ENST00000377862.6 ENST00000220856.6 [O95388-2] ENST00000250160.11 [O95388-1] O95388 ENST00000517423.5 [O95388-4] ENST00000519433.1 [O95388-3] E5RG88 |